Aethlon Medical (NASDAQ:AEMD) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a note issued to investors on Wednesday. The firm set a “sell” rating on the medical equipment provider’s stock.

Separately, HC Wainwright dropped their target price on shares of Aethlon Medical from $23.00 to $10.00 and set a “buy” rating on the stock in a report on Monday, March 4th.

Aethlon Medical Trading Down 4.0 %

Shares of AEMD stock opened at $0.41 on Wednesday. Aethlon Medical has a 12-month low of $0.37 and a 12-month high of $5.00. The firm’s 50 day moving average is $1.35 and its 200 day moving average is $1.67. The stock has a market capitalization of $1.07 million, a P/E ratio of -0.08 and a beta of 1.95.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.